Pfizer has the most products in the list of the top 30 outpatient prescriptions

Published: 2014-10-27 14:12:12

Updated: 2014-10-27 14:12:12

The pharmaceutical company with the most sales product in the collective outpatient prescription market on the third quarter of the year was, of course, Pfizer.

The current circumstance in the pharmaceutical industry literally reflects the more the better. While BMS reached KRW 100 billion only with ‘Baraclude’, Pfizer made KRW 180 billion through blockbuster-level supply releases.

According ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.